Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $100.7 million.

  • Kura Oncology's Operating Expenses rose 6823.69% to $100.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $343.8 million, marking a year-over-year change of. This contributed to the annual value of $247.1 million for FY2024, which is 4901.81% up from last year.
  • Latest data reveals that Kura Oncology reported Operating Expenses of $100.7 million as of Q3 2025, which was up 6823.69% from $88.0 million recorded in Q2 2025.
  • Kura Oncology's 5-year Operating Expenses high stood at $100.7 million for Q3 2025, and its period low was $54.5 million during Q1 2024.